Schrodinger Inc
Open
SectorGezondheidszorg
19.04 -2.21
Overzicht
Wijziging aandelenprijs
24u
Min
18.75
Max
19.55
Inkomsten | 66M 6M |
|---|---|
Verkoop | 302K 59M |
EPS | 0.08 |
Winstmarge | 10.146 |
Werknemers | 850 |
EBITDA | 65M 7.3M |
Volgende Winsten | 4 nov 2026 |
|---|
Marktkapitalisatie | 361M 1.5B |
|---|---|
Vorige openingsprijs | 21.25 |
Vorige sluitingsprijs | 19.04 |
Nieuwssentiment
By Acuity
37%
63%
103 / 339 Rangschikking in Healthcare
Schrodinger Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Schrodinger Inc Prognose
Sentiment
By Acuity
103 / 339 Rangschikking in Gezondheidszorg
Nieuwssentiment
Bullish Bewijs
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Boven gemiddelde
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Schrodinger Inc
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.